DR. XIU-MIN LI, MD
Acupuncture at Madison Ave, New York, NY

License number
New York 002888-1
Category
Acupuncture
Type
Acupuncturist
Address
Address
161 Madison Ave, New York, NY 10016
Phone
(212) 686-8689
(212) 686-8968 (Fax)

Professional information

See more information about XIU-MIN LI at trustoria.com
Xiu-Min Li Photo 1
Dr. Xiu-Min Li, New York NY - MD (Doctor of Medicine)

Dr. Xiu-Min Li, New York NY - MD (Doctor of Medicine)

Specialties:
Acupuncture
Address:
161 Madison Ave, New York 10016
(212) 686-8689 (Phone), (212) 686-8968 (Fax)
Languages:
English


Xiu-Min Li Photo 2
Xiu-Min Li, New York NY

Xiu-Min Li, New York NY

Specialties:
Acupuncturist
Address:
161 Madison Ave, New York, NY 10016
1 Gustave L Levy Pl, New York, NY 10029


Xiu-Min Li Photo 3
Medical Uses Of Glucans

Medical Uses Of Glucans

US Patent:
2010032, Dec 23, 2010
Filed:
Feb 21, 2008
Appl. No.:
12/528215
Inventors:
Rolf Seljelid - Tromso, NO
Xiu-Min Li - New York NY, US
Assignee:
BIOTEC PHARMACON ASA - Tromsø
International Classification:
A61K 39/395, A61K 31/716, A61P 11/06
US Classification:
4241331, 514 54
Abstract:
The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.


Xiu-Min Li Photo 4
Medical Uses Of Glucans

Medical Uses Of Glucans

US Patent:
2012029, Nov 22, 2012
Filed:
Jul 30, 2012
Appl. No.:
13/561353
Inventors:
Rolf SELJELID - Tromso, NO
Xiu-Min LI - New York NY, US
Assignee:
Mount Sinai School of Medicine of New York University - New York NY
Biotec Pharmacon ASA - Tromso
International Classification:
A61K 31/716, A61P 11/06, A61P 11/00, C08B 37/00
US Classification:
514 54, 53612312
Abstract:
The invention relates to a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto for use in the treatment of asthma and related diseases of abnormal pulmonary function in an animal. Also described is a method of treating asthma and related diseases of abnormal pulmonary function in an animal comprising administering to said animal an effective amount of a glucan having a beta-(1,3)-backbone with one or more beta-(1,3)-side chains linked thereto.